M&A in Medtech: The Boom in Portfolio Reshaping. A BAIN Report

https://www.bain.com/insights/medtech-m-and-a-report-2026/

As leaders refocus portfolios, dealmaking officially returns.

At a Glance

• Spin-offs and divestitures now represent more than one-third of strategic deal value.
• Category leadership, not deal size, is defining winners.